Last update 27 Dec 2024
Euclises Pharmaceuticals, Inc.

Euclises Pharmaceuticals, Inc.

Holding Company|
2011|
Missouri, United States
|
< 10
|
www.euclises.com

Overview

Tags

Neoplasms
Digestive System Disorders
Respiratory Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
COX-2(Cyclooxygenase-2)1

Related

1
Drugs associated with Euclises Pharmaceuticals, Inc.
ECP-1014
Target
COX-2
Mechanism
COX-2 inhibitors
Active Org.
Euclises Pharmaceuticals, Inc.Euclises Pharmaceuticals, Inc.
Originator Org.
Euclises Pharmaceuticals, Inc.Euclises Pharmaceuticals, Inc. [+1]
Active Indication
Colorectal Cancer [+1]
Inactive Indication
Inflammation [+1]
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Euclises Pharmaceuticals, Inc.
NCT04930354 / RecruitingPhase 1
A Phase 1 Open-Label, Multiple Dose, Two Part Dose Escalation Study of ECP-1014 as a Treatment for Patients With Solid Tumor Cancers
100 Clinical Results associated with Euclises Pharmaceuticals, Inc.
Login to view more data
0 Patents (Medical) associated with Euclises Pharmaceuticals, Inc.
Login to view more data
100 Deals associated with Euclises Pharmaceuticals, Inc.
Login to view more data
100 Translational Medicine associated with Euclises Pharmaceuticals, Inc.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 29 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
ECP-1014
 ( COX-2 )		Pain
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free